-+ 0.00%
-+ 0.00%
-+ 0.00%

ADMA BIOLOGICS ANNOUNCES FDA APPROVAL TO EXPAND THE LABEL FOR ASCENIV™ TO INCLUDE PEDIATRIC IMMUNE COMPROMISED PATIENTS TWO YEARS OF AGE AND OLDER

Reuters·05/04/2026 11:00:02

Please log in to view news